Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
IMM-101
i
Other names:
IMM-101, IMM 101, heat-killed whole cell Mycobacterium obuense suspension in borate-buffered saline, NCTC 13365, heat killed M. obuense (NCTC) 13365)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Immodulon
Drug class:
Dendritic cell activator
Related drugs:
‹
PVS-RIPO (1)
GEN-001 (0)
HER-2 pulsed DC1 (0)
ID-LV305 (0)
ilixadencel (0)
KRAS-EphA-2-CAR-DC (0)
CDX-301 (0)
NC410 (0)
ORB-011 (0)
TP53-EphA-2-CAR-DC (0)
LOAd703 (0)
DC-TC (0)
CDX-1401 (0)
personalized cellular vaccine (0)
PVS-RIPO (1)
GEN-001 (0)
HER-2 pulsed DC1 (0)
ID-LV305 (0)
ilixadencel (0)
KRAS-EphA-2-CAR-DC (0)
CDX-301 (0)
NC410 (0)
ORB-011 (0)
TP53-EphA-2-CAR-DC (0)
LOAd703 (0)
DC-TC (0)
CDX-1401 (0)
personalized cellular vaccine (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma (IMM-101-015) (NCT03711188)
Phase 2
Immodulon Therapeutics Ltd
Immodulon Therapeutics Ltd
Completed
Phase 2
Immodulon Therapeutics Ltd
Completed
Last update posted :
04/29/2024
Initiation :
10/04/2018
Primary completion :
12/02/2021
Completion :
12/02/2021
BRAF
|
BRAF mutation
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • IMM-101
Atezolizumab in Patients With MSI-h/MMR-D Stage III Colorectal Cancer Ineligible for Oxaliplatin (ANTONIO) (NCT05118724)
Phase 2
AIO-Studien-gGmbH
AIO-Studien-gGmbH
Recruiting
Phase 2
AIO-Studien-gGmbH
Recruiting
Last update posted :
12/28/2023
Initiation :
12/10/2021
Primary completion :
11/15/2026
Completion :
11/15/2026
MSI
|
MSI-H/dMMR
|
Tecentriq (atezolizumab) • oxaliplatin • IMM-101
A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer (NCT01539824)
Phase 2
Immodulon Therapeutics Ltd
Immodulon Therapeutics Ltd
Completed
Phase 2
Immodulon Therapeutics Ltd
Completed
Last update posted :
12/02/2016
Initiation :
02/01/2012
Primary completion :
08/01/2014
Completion :
08/01/2014
CRP
|
IMM-101
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login